Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study

• DOI: 10.1016/j.euo.2023.09.006
• Publication Date: 2023-10-14T11:22:12Z
• Authors: Pawel Rajwa; Daniele Robesti; Michael Chaloupka; Fabio Zattoni; Alexander Giesen; Nicolai A. Huebner; Aleksandra Krzywon; Marcin Miszczyk; Matthias Moll; Rafał Stando; Edoardo Cisero; Sofiya Semko; Enrico Checcucci; Gaëtan Devos; Maria Apfelbeck; Cecilia Gatti; Giancarlo Marra; Roderick C.N. van...; Gregor Goldner; Sazan Rasul; Francesco Ceci; Fabrizio Dal Moro; Francesco Porpiglia; Paolo Gontero; Anders Bjartell; Christian Stief; Axel Heidenreich; Steven Joniau; Alberto Briganti; Shahrokh F. Shariat; Giorgio Gandaglia
• Keywords: Glutamate carboxypeptidase II

De novo oligometastatic prostate cancer (omPCa) on prostate-specific membrane antigen (PSMA) positron emission tomography (PET) is a new disease entity and its optimal management remains unknown.